A joint therapy venture?

MANY patients with osteoarthritis (OA) pain swear by glucosamine, but with inconclusive evidence for its efficacy in symptom relief or arresting disease progression, health professionals may question its use.

Despite earlier enthusiasm from older and smaller studies for glucosamine and chondroitin in OA, recent meta-analyses have concluded that neither agent, nor a combination, has a significant effect.

However, two recent studies investigating glucosamine plus chondroitin have shown the combination protects against structural disease progression in OA of the knee.

The findings of both studies indicate